enGene Holdings Inc. (ENGN) Balance Sheet

NASDAQ: ENGNAssets, liabilities, debt and equity over 5 years.

ENGN balance sheet, FY2025

October 31, 2025 · U.S. dollars

$221.5M assets = $53.8M liabilities + $167.7M equity

What it owns$221.5MCash & ST investments: $193.8M (87.5%)Cash & ST investments$193.8M · 88%Receivables: $2.2M (1.0%)Other current: $5.3M (2.4%)PP&E: $10.2M (4.6%)LT investments: $8.5M (3.8%)Other non-current: $1.4M (0.6%)=How it is financed$221.5MCurrent liabilities: $32.0M (14.4%)Current liabilities$32.0M · 14%Long-term debt: $15.3M (6.9%)Long-term debt $15.3MOther LT liabilities: $6.5M (2.9%)Shareholders’ equity: $167.7M (75.7%)Shareholders’ equity$167.7M · 76%

Both columns are drawn to the same scale: what ENGN owns equals what it owes plus shareholders’ equity. Hover a block for its value.

ENGN financial health

Current ratio6.30
Comfortable · current assets cover current liabilities 6.30×
Debt / equity0.19
Low leverage · $0.19 of debt for each $1 of equity
Equity / assets75.7%
Equity-funded · of assets funded by shareholders
Cash / debt609.6%
Cash covers debt · cash & short-term investments vs total debt
Goodwill & intangibles0.0%
Mostly tangible · of total assets

Descriptive bands, not a rating. Fiscal FY2025.

ENGN balance sheet trends, FY2021–FY2025

enGene Holdings Inc. balance sheet trends
MetricTrendThenLatestChange
Total assets$131.4MFY2021$221.5MFY2025+13.9%/yr
Total liabilities$4.1MFY2021$53.8MFY2025+90.8%/yr
Shareholders’ equity$127.4MFY2021$167.7MFY2025+7.1%/yr
Cash & short-term investments$1.1MFY2021$193.8MFY2025+266.9%/yr
Total debt$4.2MFY2021$31.8MFY2025+66.3%/yr
Net cash (debt)−$3.1MFY2021$162.0MFY2025+$165.1M
Working capital$1.2MFY2021$169.4MFY2025+$168.2M
Book value per share$8.06FY2021$3.28FY2025−20.1%/yr
Current ratio4.79FY20216.30FY2025+1.51
Debt / equity0.03FY20210.19FY2025+0.16
Shares outstanding15.8MFY202151.1MFY2025+34.1%/yr

Change is the average annual growth (CAGR) or the difference between the first and latest year.

ENGN assets

Cash & ST investmentsReceivablesInventoryOther currentPP&EGoodwill & intangiblesLT investmentsOther non-current

ENGN liabilities and equity

Current liabilitiesLong-term debtOther long-term liabilitiesEquity

ENGN debt vs cash

Total debtCash & ST investmentsNet cash (debt)

Debt includes short- and long-term borrowings and, where reported, lease obligations.

ENGN balance sheet

enGene Holdings Inc. annual balance sheet
FY2025FY2024FY2023FY2022FY2021
Assets
Cash & short-term investments$193.8M$238.4M$81.6M$314,151$1.1M
Cash & equivalents$50.2M$173.0M$81.5M$314,151$1.1M
Short-term investments$143.7M$65.4M$76,000——
Receivables$2.2M$1.0M$2.3M$1.3M$1.6M
Inventory$0$0$76,000$74,000$81,000
Other current assets$5.3M$7.9M$1.4M$0$0
Total current assets$201.4M$247.4M$85.4M$511,804$1.6M
Property, plant & equipment (net)$10.2M$2.9M$589,000$387,000$571,000
Goodwill & intangible assets$0$0$0$0$0
Long-term investments$8.5M$59.5M$0$0$0
Other non-current assets$1.4M$1.4M$930,000$131.1M$129.3M
Total assets$221.5M$311.2M$87.0M$132.0M$131.4M
Liabilities
Accounts payable$6.7M$1.4M$1.2M$723,000$1.0M
Short-term debt$10.0M$1.1M$562,000$1.3M$1.0M
Deferred revenue——$3.3M—$1.1M
Total current liabilities$32.0M$14.7M$5.3M$893,509$327,447
Long-term debt$15.3M$22.5M$9.2M$30.8M$3.0M
Lease obligations$8.5M$1.9M$0$0$61,000
Other long-term liabilities$6.5M$1.4M$0$0$680,500
Total liabilities$53.8M$38.6M$14.5M$4.6M$4.1M
Shareholders' equity
Common stock & paid-in capital$513.3M$509.8M$259.4M$131.5M$129.7M
Retained earnings (deficit)−$372.0M−$254.7M−$199.6M−$4.1M−$2.3M
Accumulated other comprehensive income−$888,000−$1.4M−$1.0M−$1.0M−$2.2M
Total shareholders' equity$167.7M$272.6M$72.5M$127.4M$127.4M
Key figures
Total debt$31.8M$25.0M$9.8M$32.1M$4.2M
Net cash (debt)$162.0M$213.4M$71.8M−$31.8M−$3.1M
Working capital$169.4M$232.7M$80.2M−$381,705$1.2M
Tangible book value$167.7M$272.6M$72.5M$127.4M$127.4M
Book value per share$3.28$6.11$3.08$8.06$8.06
Shares outstanding51.1M44.6M23.6M15.8M15.8M
Current ratio6.3016.8716.250.574.79
Quick ratio6.1316.3315.971.858.22
Debt / equity0.190.090.130.250.03
Equity / assets75.7%87.6%83.4%96.5%96.9%

Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported (latest annual report filed December 22, 2025); data from EODHD.

ENGN financial position

At the end of fiscal 2025 (October 31, 2025), enGene had total assets of $221.5 million (down 28.8% from a year earlier), total liabilities of $53.8 million and shareholders' equity of $167.7 million. It held $193.8 million in cash and short-term investments against $31.8 million of debt, a net cash position of $162.0 million. Its current ratio was 6.30. In the latest quarter (ended July 31, 2026) total assets were $288.3 million and equity $230.3 million.

Related: ENGN income statement, ENGN cash flow statement, ENGN key metrics. See the ENGN stock overview for the latest quote and news.

ENGN balance sheet FAQ

What are enGene's total assets?

enGene reported total assets of $221.5 million at the end of fiscal 2025 (October 31, 2025), compared with $311.2 million a year earlier.

How much debt does enGene have?

enGene had $31.8 million of total debt at the end of fiscal 2025, including short-term borrowings and lease obligations. Its debt-to-equity ratio was 0.19.

How much cash does enGene have?

enGene held $193.8 million in cash and short-term investments at the end of fiscal 2025; with $31.8 million of debt that is net cash of $162.0 million.

What is enGene's book value?

enGene's shareholders' equity (book value) was $167.7 million at the end of fiscal 2025, or $3.28 per share.

What is enGene's current ratio?

enGene had current assets of $201.4 million and current liabilities of $32.0 million, a current ratio of 6.30 (it can cover its short-term obligations).

Biotechnology: balance sheet